Russell Investments Group’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.97M Buy
105,434
+14,355
+16% +$469K ﹤0.01% 1485
2025
Q4
$2.74M Buy
91,079
+59,297
+187% +$1.68M ﹤0.01% 1696
2025
Q3
$834K Sell
31,782
-61,810
-66% -$1.47M ﹤0.01% 2276
2025
Q2
$1.99M Buy
93,592
+3,191
+4% +$72K ﹤0.01% 1716
2025
Q1
$1.92M Buy
90,401
+17,160
+23% +$352K ﹤0.01% 1721
2024
Q4
$1.48M Buy
73,241
+57,475
+365% +$1.19M ﹤0.01% 1808
2024
Q3
$265K Buy
+15,766
New +$266K ﹤0.01% 2448

Other funds holding GRDN

Russell Investments Group's GRDN Position: Q1 2026 in Review

Russell Investments Group increased its Guardian Pharmacy Services (GRDN) stake by 16% in Q1 2026, buying an estimated $469K and bringing the position to 105,434 shares worth $3.97M. The position accounts for ﹤0.01% of the portfolio, ranked #1485.

Russell Investments Group first reported a position in GRDN in Q3 2024 and has held it in 7 quarters since. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • Russell Investments Group held 105,434 shares of Guardian Pharmacy Services worth $3.97M as of Q1 2026.
  • Russell Investments Group bought 14,355 Guardian Pharmacy Services shares in Q1 2026, an estimated $469K.
  • Guardian Pharmacy Services made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #1485 holding.
  • Russell Investments Group first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 7 quarters since.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.